19-16325450-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_016270.4(KLF2):āc.310C>Gā(p.Leu104Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000778 in 1,414,374 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L104P) has been classified as Likely benign.
Frequency
Consequence
NM_016270.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000660 AC: 1AN: 151626Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000792 AC: 10AN: 1262748Hom.: 0 Cov.: 33 AF XY: 0.00000482 AC XY: 3AN XY: 622008
GnomAD4 genome AF: 0.00000660 AC: 1AN: 151626Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74040
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 30, 2024 | The c.310C>G (p.L104V) alteration is located in exon 2 (coding exon 2) of the KLF2 gene. This alteration results from a C to G substitution at nucleotide position 310, causing the leucine (L) at amino acid position 104 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at